Kefir probiotic beverage maker Lifeway Foods announced on Thursday that its shareholder, Danone's American public benefit corporation, will sell approximately 3.45 million shares of common stock through a secondary public offering at a price of $19.50 per share. Affected by the discounted offering, the company's stock price fell in pre-market trading.
Offering Details and Discount According to the company announcement, the total offering consists of 3,454,756 shares, all from Danone. Lifeway itself is not selling any shares and will not receive any proceeds from the transaction. The offering price of $19.50 per share represents a significant discount of approximately 28% compared to Wednesday's closing price of $27.25. BTIG is acting as the sole book-running manager for the offering, which is expected to be completed and settled by May 19, 2026.
Concurrent Buyback and Financial Strength To mitigate the market impact of the major shareholder's sale, Lifeway has agreed to repurchase approximately $5 million worth of shares at the same price. This buyback is contingent upon the completion of the offering, but the offering itself is not contingent upon the completion of the buyback.
Despite the stock price pressure, Lifeway's fundamentals remain robust. The company's recently reported first-quarter earnings showed earnings per share of $0.30, significantly exceeding the market expectation of $0.20. Quarterly revenue reached $63.01 million, also surpassing the consensus estimate of $53 million. Revenue over the past twelve months was $212.5 million, representing a 14% year-over-year increase. Analysts note that Danone's discounted share sale is purely a shareholder-level transaction, not involving any dilution from a company issuance. Coupled with the concurrent buyback and strong financial performance, this may present a potential window of opportunity for long-term investors.
Comments